Cabaletta Bio, Inc.
HealthcareNASDAQ:CABA · NASDAQ Global Select
+$0.00 today
Vol 2.89M · Avg 3.50M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+51.26%
Period High
$4.15
Period Low
$1.33
Latest
$3.01
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Capricor Therapeutics, Inc.
NASDAQ:CAPR
$1.18B
Allogene Therapeutics, Inc.
NASDAQ:ALLO
$463.35M
Atea Pharmaceuticals, Inc.
NASDAQ:AVIR
$359.32M
Kyverna Therapeutics, Inc.
NASDAQ:KYTX
$352.74M
Lexeo Therapeutics, Inc. Common Stock
NASDAQ:LXEO
$343.14M
Lyell Immunopharma, Inc.
NASDAQ:LYEL
$315.01M
Editas Medicine, Inc.
NASDAQ:EDIT
$244.75M
Humacyte, Inc.
NASDAQ:HUMA
$177.24M
ProQR Therapeutics N.V.
NASDAQ:PRQR
$151.72M
Immutep Limited
NASDAQ:IMMP
$53.60M
What is the latest CABA filing?
The latest filing shown is 8-K dated Jun 11, 2026.
How many recent filings does CABA have?
Intrinsic Alpha currently shows 20 recent filings for CABA.
Explore More
Continue the stock analysis
Jump to another research area for this company.